Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial

Haemophilia - United Kingdom
doi 10.1111/hae.13807
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision

Turkish Journal of Haematology
Hematology
2019English

Desmopressin Treatment Combined With Clotting Factor VIII Concentrates in Patients With Non-Severe Haemophilia A: Protocol for a Multicentre Single-Armed Trial, the DAVID Study

BMJ Open
Medicine
2019English

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial

The Lancet
Medicine
2008English

Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B

Haemophilia
MedicineGeneticsHematology
2019English

Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
1981English

Tocilizumab in Patients With Anti-TNF Refractory Juvenile Idiopathic Arthritis-Associated Uveitis (APTITUDE): A Multicentre, Single-Arm, Phase 2 Trial

Lancet Rheumatology, The
RheumatologyAllergyImmunology
2020English

Turoctocog Alfa Pegol Provides Effective Management for Major and Minor Surgical Procedures in Patients Across All Age Groups With Severe Haemophilia A: Full Data Set From the Pathfinder 3 and 5 Phase III Trials

Haemophilia
MedicineGeneticsHematology
2020English

Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy